Pallas Capital Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,661	Closed	-$797K	–	975
2025 Q4	$797K	Hold	22,661	–	–	0.03%	412
2025 Q3	$596K	Buy	22,661 +386	+2%	+$11.5K	0.02%	475
2025 Q2	$590K	Buy	22,275 +1,127	+5%	+$29.7K	0.02%	450
2025 Q1	$511K	Sell	21,148 -92	-0.4%	-$2.91K	0.02%	457
2024 Q4	$855K	Sell	21,240 -165	-0.8%	-$9.41K	0.04%	264
2024 Q3	$1.57M	Buy	21,405 +2,062	+11%	+$121K	0.07%	167
2024 Q2	$969K	Buy	19,343 +4,426	+30%	+$290K	0.04%	216
2024 Q1	$1.22M	Buy	14,917 +551	+4%	+$24.5K	0.05%	193
2023 Q4	$267K	Buy	14,366 +917	+7%	+$12K	0.01%	327
2023 Q3	$129K	Hold	13,449	–	–	0.01%	337
2023 Q2	$208K	Buy	+13,449	New	+$282K	0.01%	251